MeSH tree: C10.292.700.600
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a slightly higher risk of ischemic optic neuropathy (ION), a rare condition involving ...
Jul 13, 2026
0
7
The phrase "eye stroke" has recently appeared in news reports about a very rare side effect of weight-loss injections. It's not a formal medical diagnosis, but a shorthand used to describe a condition in which reduced blood ...
Mar 18, 2026
0
10
Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published ...
Mar 10, 2026
0
76
People with type 2 diabetes starting semaglutide have more than a doubled risk for nonarteritic anterior ischemic optic neuropathy (NAION) versus those starting sodium-glucose cotransporter-2 inhibitors (SGLT2is), according ...
Feb 23, 2026
0
11
A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergized the impacts of worldwide clinical trial data through ...
Feb 6, 2026
0
20
